Yi Mo

Yi Mo, PhD, is a specialized expert in clinical research focused on Alzheimer's disease and other neurodegenerative conditions. They served as a Senior Director at Merck and Axovant Sciences, leading critical clinical trials and development programs. Previously, Yi held roles at Schering-Plough Research Institute and Eisai US, contributing significantly to study designs and regulatory submissions in Alzheimer's research. Yi completed their PhD in Biochemistry/Structural Biology at the University of Pennsylvania and has transitioned to a freelance consultancy role after retiring from Eisai.